Oculis Holding AG (OCS) Cash & Equivalents (2021 - 2026)

Oculis Holding AG (OCS) recorded quarterly Cash & Equivalents of $103.9 million in Q1 2026, up 2.06% quarter-over-quarter from $101.8 million in Q4 2025, and up 237.0% on a YoY basis from $30.8 million in Q1 2025.

Oculis Holding AG (OCS) Cash & Equivalents (2021 - 2026) Analysis & Trends

Oculis Holding AG's Cash & Equivalents history runs 6 years deep, the most recent figure standing at $103.9 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents rose 237.0% year-over-year to $103.9 million; the TTM figure through Mar 2026 stood at $103.9 million (up 237.0% YoY), while the FY2025 annual figure was $101.8 million, up 221.72% from the prior year.
  • Cash & Equivalents was $103.9 million for Q1 2026 at Oculis Holding AG, up from $101.8 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $103.9 million in Q1 2026 to a low of $20.5 million in Q4 2022.
  • Historically, Cash & Equivalents has averaged $44.7 million across 5 years, with a median of $38.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Cash & Equivalents slumped 59.08% in 2022, then surged 237.0% in 2026.
  • A 5-year view of Cash & Equivalents shows it stood at $20.5 million in 2022, then grew by 8.61% to $22.3 million in 2023, then jumped by 41.8% to $31.6 million in 2024, then soared by 221.72% to $101.8 million in 2025, then increased by 2.06% to $103.9 million in 2026.
  • The last three Cash & Equivalents figures came in at $103.9 million (Q1 2026), $101.8 million (Q4 2025), and $34.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 32.30 Mn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 1.91 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 2.77 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - 18.44 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 5.49 Bn
9 Abivax 90.15 Bn 90.15 Bn - 558.94 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 103.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 103.86 Mn
Dec 31, 2025 101.76 Mn
Sep 30, 2025 34.64 Mn
Jun 30, 2025 77.63 Mn
Mar 31, 2025 30.82 Mn
Dec 31, 2024 31.63 Mn
Sep 30, 2024 44.24 Mn
Jun 30, 2024 42.38 Mn
Mar 31, 2024 43.91 Mn
Dec 31, 2023 22.31 Mn
Sep 30, 2023 22.40 Mn
Jun 30, 2023 22.01 Mn
Mar 31, 2023 21.39 Mn
Dec 31, 2022 20.54 Mn
Sep 30, 2022 47.92 Mn
Jun 30, 2022 48.05 Mn
Dec 31, 2021 50.19 Mn